AVENUE THERAPEUTICS INC - COM (ATXI)

CUSIP: 05360L304

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Equity / COM
Total 13F shares
416,756
Share change
-32,057
Total reported value
$486,116
Price per share
$1.17
Number of holders
12
Value change
-$36,478
Number of buys
8
Number of sells
8

Quarterly Holders Quick Answers

What is CUSIP 05360L304?
CUSIP 05360L304 identifies ATXI - AVENUE THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AVENUE THERAPEUTICS INC - COM (ATXI) as of Q1 2023

As of 31 Mar 2023, AVENUE THERAPEUTICS INC - COM (ATXI) was held by 12 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 416,756 shares. The largest 10 holders included SABBY MANAGEMENT, LLC, Bank of New York Mellon Corp, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, SHIKIAR ASSET MANAGEMENT INC, Tower Research Capital LLC (TRC), WELLS FARGO & COMPANY/MN, BlackRock Inc., and EMFO, LLC. This page lists 12 institutional shareholders reporting positions in this security for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.